+151.5%
MET vs BBIO
+136.7%
+14.9%
-55.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.4% | -0.1% | +0.5% | +0.4% |
| 7D | -0.5% | -3.2% | +2.7% | -0.3% |
| 30D | +0.5% | -13.6% | +14.1% | +1.6% |
| 3M | +11.6% | +7.2% | +4.4% | +10.8% |
| 6M | +40.8% | +1.5% | +39.3% | +40.2% |
| YTD | +25.7% | -5.3% | +31.0% | +25.5% |
| 1Y | +24.4% | +37.7% | -13.4% | +20.4% |
| 3Y | +67.5% | +153.9% | -86.4% | +51.6% |
| 5Y | +85.8% | +43.9% | +41.9% | +59.6% |
| All | +151.5% | +136.7% | +14.9% | +84.2% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling